J&J resumes US rollout of Varipulse heart device after investigation
Portfolio Pulse from
Johnson & Johnson has resumed the limited market release of its Varipulse heart device in the US after an investigation confirmed the devices function as intended.
February 15, 2025 | 5:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson has resumed the US rollout of its Varipulse heart device following an investigation that confirmed the device operates as intended.
The resumption of the Varipulse heart device rollout is positive for J&J as it indicates resolution of any prior issues and potential for increased sales in the medical device segment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100